Claudia Weiß

7PUBLICATIONS
61CO-AUTHORS
Molecular targetsPharmacogenomicsGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.

|Apr 11, 2026
Risdiplam Add-On Therapy Following Onasemnogene Abeparvovec in Children With Spinal Muscular Atrophy and 2 SMN2 Copies: A Multi-Center Case Series.

Corinna Stoltenburg, Klaus Goldhahn, Arpad von Moers

|Nov 24, 2025
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.

Claudia Weiß, Katharina Vill, Matthias Baumann

|Jul 22, 2024
Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.

Axel Schmidt, Magdalena Danyel, Kathrin Grundmann

Pageof 2

Frequent Collaborators

4 joint publications

Markus Schülke

2 joint publications

Axel Schmidt

2 joint publications

Theresa Brunet

2 joint publications

Hannah Klinkhammer